These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 24802849)
1. Fas/Fas ligand mediates keratinocyte death in sunitinib-induced hand-foot skin reaction. Yeh CN; Chung WH; Su SC; Chen YY; Cheng CT; Lin YL; Chang WC; Chung-Yee Hui R; Chiang KC; Chen TW; Jan YY; Chen CW; Chen TJ; Yang CH; Hung SI J Invest Dermatol; 2014 Nov; 134(11):2768-2775. PubMed ID: 24802849 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib. Lee WJ; Lee JL; Chang SE; Lee MW; Kang YK; Choi JH; Moon KC; Koh JK Br J Dermatol; 2009 Nov; 161(5):1045-51. PubMed ID: 19558553 [TBL] [Abstract][Full Text] [Related]
3. Discrimination of hand-foot skin reaction caused by tyrosine kinase inhibitors based on direct keratinocyte toxicity and vascular endothelial growth factor receptor-2 inhibition. Hasan Alshammari A; Masuo Y; Fujita KI; Shimada K; Iida N; Wakayama T; Kato Y Biochem Pharmacol; 2022 Mar; 197():114914. PubMed ID: 35041812 [TBL] [Abstract][Full Text] [Related]
4. Risk of hand-foot skin reaction with the multitargeted kinase inhibitor sunitinib in patients with renal cell and non-renal cell carcinoma: a meta-analysis. Chu D; Lacouture ME; Weiner E; Wu S Clin Genitourin Cancer; 2009 Jan; 7(1):11-9. PubMed ID: 19213662 [TBL] [Abstract][Full Text] [Related]
5. Fas/FasL pathway and cytokines in keratinocytes in atopic dermatitis - Manipulation by the electromagnetic field. Szymanski L; Cios A; Lewicki S; Szymanski P; Stankiewicz W PLoS One; 2018; 13(10):e0205103. PubMed ID: 30286163 [TBL] [Abstract][Full Text] [Related]
6. Soluble Fas Ligand Is Essential for Blister Formation in Pemphigus. Lotti R; Shu E; Petrachi T; Marconi A; Palazzo E; Quadri M; Lin A; O'Reilly LA; Pincelli C Front Immunol; 2018; 9():370. PubMed ID: 29535737 [TBL] [Abstract][Full Text] [Related]
7. Intracellular localization of keratinocyte Fas ligand explains lack of cytolytic activity under physiological conditions. Viard-Leveugle I; Bullani RR; Meda P; Micheau O; Limat A; Saurat JH; Tschopp J; French LE J Biol Chem; 2003 May; 278(18):16183-8. PubMed ID: 12473659 [TBL] [Abstract][Full Text] [Related]
8. FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major. Eidsmo L; Fluur C; Rethi B; Eriksson Ygberg S; Ruffin N; De Milito A; Akuffo H; Chiodi F Am J Pathol; 2007 Jan; 170(1):227-39. PubMed ID: 17200196 [TBL] [Abstract][Full Text] [Related]
9. Loss of FAS/FASL signalling does not reduce apoptosis in Sharpin null mice. Potter CS; Silva KA; Kennedy VE; Stearns TM; HogenEsch H; Sundberg JP Exp Dermatol; 2017 Sep; 26(9):820-822. PubMed ID: 28094869 [TBL] [Abstract][Full Text] [Related]
10. Distinct different sensitivity of Treg and Th17 cells to Fas-mediated apoptosis signaling in patients with acute coronary syndrome. Li Q; Wang Y; Wang Y; Zhou Q; Chen K; Wang YM; Wei W; Wang Y Int J Clin Exp Pathol; 2013; 6(2):297-307. PubMed ID: 23330016 [TBL] [Abstract][Full Text] [Related]
11. Management of tyrosine kinase inhibitor-induced hand-foot skin reaction: viewpoints from the medical oncologist, dermatologist, and oncology nurse. Manchen E; Robert C; Porta C J Support Oncol; 2011; 9(1):13-23. PubMed ID: 21465734 [TBL] [Abstract][Full Text] [Related]
12. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway. Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974 [TBL] [Abstract][Full Text] [Related]
13. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Hill LL; Ouhtit A; Loughlin SM; Kripke ML; Ananthaswamy HN; Owen-Schaub LB Science; 1999 Aug; 285(5429):898-900. PubMed ID: 10436160 [TBL] [Abstract][Full Text] [Related]
14. FasL shedding is reduced by hypothermia in experimental stroke. Liu L; Kim JY; Koike MA; Yoon YJ; Tang XN; Ma H; Lee H; Steinberg GK; Lee JE; Yenari MA J Neurochem; 2008 Jul; 106(2):541-50. PubMed ID: 18410517 [TBL] [Abstract][Full Text] [Related]
15. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio. Chien MH; Chang WM; Lee WJ; Chang YC; Lai TC; Chan DV; Sharma R; Lin YF; Hsiao M Mol Cancer Ther; 2017 Jun; 16(6):1102-1113. PubMed ID: 28292939 [TBL] [Abstract][Full Text] [Related]
16. The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis. Eidsmo L; Nylen S; Khamesipour A; Hedblad MA; Chiodi F; Akuffo H Am J Pathol; 2005 Apr; 166(4):1099-108. PubMed ID: 15793290 [TBL] [Abstract][Full Text] [Related]
17. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494 [TBL] [Abstract][Full Text] [Related]
18. Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib. Lacouture ME; Reilly LM; Gerami P; Guitart J Ann Oncol; 2008 Nov; 19(11):1955-61. PubMed ID: 18550575 [TBL] [Abstract][Full Text] [Related]
19. D4F alleviates macrophage-derived foam cell apoptosis by inhibiting the NF-κB-dependent Fas/FasL pathway. Tian H; Yao ST; Yang NN; Ren J; Jiao P; Zhang X; Li DX; Zhang GA; Xia ZF; Qin SC Sci Rep; 2017 Aug; 7(1):7333. PubMed ID: 28779128 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of Fas on human epidermal cells after in vivo exposure to single-dose ultraviolet (UV) B or long-wave UVA radiation. Bang B; Rygaard J; Baadsgaard O; Skov L Br J Dermatol; 2002 Dec; 147(6):1199-206. PubMed ID: 12452871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]